US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Biora Therapeutics Inc (PROG)
Biora Therapeutics Inc (PROG) ニュース

PROG

Biora Therapeutics (PROG)

Biora Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PROG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/17	05 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/17	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/17	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/17	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/16	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/13	23 : 26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/13	23 : 26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PROG	Biora Therapeutics Inc
2023/06/09	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/05/18	05 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/05/18	05 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/05/16	05 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/04/28	05 : 41	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:PROG	Biora Therapeutics Inc
2023/04/28	05 : 34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PROG	Biora Therapeutics Inc
2023/04/08	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/03/31	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/03/14	05 : 19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/28	07 : 02	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/21	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/13	06 : 47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/12	20 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/10	06 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/06	06 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/06	06 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/06	06 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/06	06 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2023/01/06	06 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PROG	Biora Therapeutics Inc
2022/12/30	23 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc
2022/12/10	07 : 04	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PROG	Biora Therapeutics Inc
2022/11/30	06 : 31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PROG	Biora Therapeutics Inc
2022/11/29	08 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PROG	Biora Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:PROG

1 2 3 4 5 6 7 8 9 10 次へ >>

Akbank 5.000% S

ICTS International NV (QB)

Kermode Resources (PK)

Desjardins RI USA Multif...

Dividend 15 Split Corp II

Delivery Technology Solu... (CE)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約